支气管内活瓣减容改善肺气肿患者心脏前负荷、收缩力及心输出量
主要终点右心室舒张末期容积指数显著改善(+7.9 ml/m2,P=0.001),心输出量增加(+0.9 L/min,P=0.007),肺动脉压无变化。
要点
- BLVR减容可显著改善右心室前负荷(RVEDVI +7.9 ml/m2)。
- 术后8周心输出量增加(+0.9 L/min),收缩功能和应变改善。
- 肺动脉压未见升高,提示肺血管床减少未导致压力上升。
核心结论
- 支气管内活瓣肺减容术减轻过度充气可显著改善心脏前负荷、心肌收缩力及心输出量,且不改变肺动脉压。
主要发现
- 右心室舒张末期容积指数显著改善(+7.9 ml/m2,SD 10.0,P=0.001)。
- 心输出量显著增加(+0.9 L/min,SD 1.5,P=0.007)。
- 射血分数及应变测量显著升高,每搏输出量增加。
- 肺动脉压无变化。
临床怎么用
- 对重度肺气肿伴过度充气患者,BLVR减容在改善肺过度充气的同时可能带来心脏前负荷和收缩功能的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Pulmonary hyperinflation in patients with chronic obstructive pulmonary disease has been related to smaller cardiac chamber sizes and impaired cardiac function. Currently, bronchoscopic lung volume reduction (BLVR) with endobronchial valves is a treatment option to reduce pulmonary hyperinflation in patients with severe emphysema. Objectives: We hypothesized that reduction of hyperinflation would improve cardiac preload in this patient group. In addition, we investigated whether the treatment would result in elevated pulmonary artery pressures because of pulmonary vascular bed reduction. Methods: We included patients with emphysema and severe hyperinflation (defined by a baseline residual volume >175% of predicted) who were eligible for BLVR with endobronchial valves. Cardiac magnetic resonance imaging was obtained one day before treatment and at 8-week follow-up. Primary endpoint was cardiac preload, as measured by the right ventricle end-diastolic volume index. As secondary endpoints, we measured indexed end-diastolic and end-systolic volumes of the right ventricle, left atrium, and left ventricle; pulmonary artery pressures; cardiac output; ejection fraction; and strain. Measurements and Main Results: Twenty-four patients were included. At 8-week follow-up, right ventricle end-diastolic volume index was significantly improved (+7.9 ml/m2; SD, 10.0; P = 0.001). In addition to increased stroke volumes, we found significantly higher ejection fractions and strain measurements. Although cardiac output was significantly increased (+0.9 L/min; SD, 1.5; P = 0.007), there were no changes in pulmonary artery pressures. Conclusions: We found that reduction of hyperinflation using BLVR with endobronchial valves significantly improved cardiac preload, myocardial contractility, and cardiac output, without changes in pulmonary artery pressures. Clinical trial registered with www.clinicaltrials.gov (NCT03474471).
引用
- van der Molen MC, Hartman JE, Vanfleteren LEGW, et al. Reduction of Lung Hyperinflation Improves Cardiac Preload, Contractility, and Output in Emphysema: A Clinical Trial in Patients Who Received Endobronchial Valves. Am J Respir Crit Care Med. 2022. PMID: 35584341. doi:10.1164/rccm.202201-0214OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。